Koligo Therapeutics (ASX:KOL) Other Operating Expense: A$ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Koligo Therapeutics Other Operating Expense?

Koligo Therapeutics ASX:KOL Other Operating Expense is A$ Mil as of . 20.

Koligo Therapeutics's Other Operating Expense for the six months ended in . 20 was A$0.00 Mil. Koligo Therapeutics does not have enough years/quarters to calculate its Other Operating Expense for the trailing twelve months (TTM) ended in . 20.

Koligo Therapeutics Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Other Operating Expense Chart

Koligo Therapeutics Annual Data
Trend
Other Operating Expense

Koligo Therapeutics Semi-Annual Data
Other Operating Expense

Koligo Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of A$ Mil mean?
Koligo Therapeutics (ASX:KOL) has a Other Operating Expense of A$ Mil as of . 20. Other operating expenses that a company records on its income statement. View historical data on Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' Other Operating Expense too high?
Koligo Therapeutics' current Other Operating Expense is A$ Mil.
How does Koligo Therapeutics' Other Operating Expense compare to ?
Koligo Therapeutics' Other Operating Expense of A$ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Koligo Therapeutics and its competitors. Koligo Therapeutics's current Other Operating Expense is A$ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Other Operating Expense of A$ Mil. The current Other Operating Expense is A$ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Other Operating Expense is A$ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies